1. Home
  2. CDT vs CREG Comparison

CDT vs CREG Comparison

Compare CDT & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • CREG
  • Stock Information
  • Founded
  • CDT 2019
  • CREG N/A
  • Country
  • CDT United States
  • CREG China
  • Employees
  • CDT N/A
  • CREG N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • CREG Power Generation
  • Sector
  • CDT Health Care
  • CREG Utilities
  • Exchange
  • CDT Nasdaq
  • CREG Nasdaq
  • Market Cap
  • CDT 5.2M
  • CREG 4.8M
  • IPO Year
  • CDT N/A
  • CREG N/A
  • Fundamental
  • Price
  • CDT $1.64
  • CREG $1.39
  • Analyst Decision
  • CDT
  • CREG
  • Analyst Count
  • CDT 0
  • CREG 0
  • Target Price
  • CDT N/A
  • CREG N/A
  • AVG Volume (30 Days)
  • CDT 95.0K
  • CREG 4.5M
  • Earning Date
  • CDT 08-26-2025
  • CREG 08-14-2025
  • Dividend Yield
  • CDT N/A
  • CREG N/A
  • EPS Growth
  • CDT N/A
  • CREG N/A
  • EPS
  • CDT N/A
  • CREG N/A
  • Revenue
  • CDT N/A
  • CREG $82,839.00
  • Revenue This Year
  • CDT N/A
  • CREG N/A
  • Revenue Next Year
  • CDT N/A
  • CREG N/A
  • P/E Ratio
  • CDT N/A
  • CREG N/A
  • Revenue Growth
  • CDT N/A
  • CREG N/A
  • 52 Week Low
  • CDT $1.61
  • CREG $1.11
  • 52 Week High
  • CDT $274.80
  • CREG $14.70
  • Technical
  • Relative Strength Index (RSI)
  • CDT 29.41
  • CREG 36.08
  • Support Level
  • CDT $1.66
  • CREG $1.11
  • Resistance Level
  • CDT $1.85
  • CREG $1.68
  • Average True Range (ATR)
  • CDT 0.11
  • CREG 0.28
  • MACD
  • CDT 0.03
  • CREG 0.06
  • Stochastic Oscillator
  • CDT 8.36
  • CREG 18.67

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

Share on Social Networks: